Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
Funded at University of Louisiana at Lafayette · NIH-10138760 · Data updated 2026-11-12
This study is looking at how well different HIV vaccines work using nonhuman primates, with the goal of finding effective ways to protect people from HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2020 |
| Award (this year) | $106,127 |
| NIH project number | 75N93020D00008-0-759302000002-1 |
| Project ID | NIH-10138760 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV who may eventually receive effective vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV and are seeking treatment rather than prevention may not directly benefit from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate the effectiveness of HIV vaccines and prevention strategies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for preclinical studies, allowing researchers to assess immune responses and vaccine efficacy. By conducting thorough evaluations, the program aims to identify vaccines that can generate protective immune responses against HIV. This initiative supports all stages of AIDS vaccine research, from initial testing to clinical applications.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent or control HIV infection in humans.
How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach has the potential for success.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.